One study employed macrophage corpses as drug delivery vehicles to activate AMPK and indirectly upregulate UCP2 for the treatment of rheumatoid arthritis (31), a strategy that may also be applicable to KOA. This evidence concerns the gene UCP2 and rheumatoid arthritis.